NARSAD
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Maria Cecilia Angulo, Ph.D. (Young Investigator 2005) of ESPCI-Ecole Superieure de Physique et Chemie Industrielles de la Ville de Paris, hopes to study the role of nicotinic acetylcholine receptors (nACHR) and monoamine oxidase B (MAO-B) in astrocytes and their possible role in schizophrenia and smoking. Astrocytes are a type of glial cell, which are numerous, non-neuronal structural cells in the brain that interact with neurons. Astrocytes express nACHRs—a mutation in which has been linked to schizophrenia—that lead to intracellular calcium ion increases in cell culture. These calcium ion increases elicit the release of gliotransmitters, such as glutamate and ATP, onto neurons, inducing synaptic activity changes. Glial nAChRs are therefore good candidates for regulating “gliotransmission.” Glial MAO-Bs also are implicated in the effects of tobacco. Dr. Angulo hypothesizes that a reduction in MAO-B activity may synergize with nicotine to produce smoking behavioral effects. Many schizophrenics smoke. The study’s goal is to understand the synergistic effect of glial nAChR activity and MAO-B inhibition in modulating synaptic neurotransmission. First, the researchers will characterize nAChR subunits preferentially expressed by astrocytes. Second, they will characterize the influence of both glial nAChRs and MAO-B inhibitors in neuronal plasticity using genetically engineered mice in which nAChRs have been disrupted. This project should tease apart the functioning of the cholinergic system and its role in schizophrenia and tobacco addiction.

Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia\Nicotine

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award Application Deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Awards Earliest Start Date: September 15, 2008

2009 Independent Investigator Award Application Deadline: March 5, 2009

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009
NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us